A Case of Conversion Surgery Following Combined Chemotherapy with Molecular Targeting Agent for Unresectable Colorectal Liver Metastases
Journal: Gan To Kagaku Ryoho. Cancer & Chemotherapy
Published:
Abstract
A 76-year-old woman complaining of constipation was diagnosed with advanced rectosigmoid colon cancer with unresectable liver metastases. We performed a laparoscopic high-anterior resection due to the obstruction. The patient then received a capecitabine plus oxaliplatin(CapeOX)plus cetuximab(Cmab)combination chemotherapy. After 7 cycles of CapeOX with Cmab, the multiple liver metastases had reduced remarkably in size. Therefore, a liver metastases resection was performed. The patient underwent 6 cycles of postoperative CapeOX with Cmab therapy and has survived 7 years with no recurrence after the primary surgery.
Authors
Takuya Inoue, Junichi Hasegawa, Koji Mikuriya, Daiki Marukawa, Yusuke Makutani, Yuki Ozato, Naoki Shinno, Haruna Furukawa, Masanori Sueda, Tae Matsumura, Chikato Koga, Masahiro Murakami, Ryohei Kawabata, Shingo Noura, Junzo Shimizu
Relevant Conditions